Role of transforming growth factor-α-related peptides in the autocrine/paracrine control of experimental breast cancer growthin vitro by estradiol, prolactin, and progesterone

[1]  Robert L. Mason,et al.  Statistical Principles in Experimental Design , 2003 .

[2]  L. Murphy,et al.  Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens. , 1989, Cancer research.

[3]  C. Osborne,et al.  Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer. , 1988, Molecular endocrinology.

[4]  L. Murphy,et al.  Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. , 1988, Cancer research.

[5]  L. Demers,et al.  Species-specificity of estradiol regulated growth factors in breast cancer. , 1988, European journal of cancer & clinical oncology.

[6]  L. Demers,et al.  Polyamines and autocrine control of N-nitrosomethylurea-induced rat mammary tumor growth in vitro by progesterone. , 1988, Cancer research.

[7]  S. Bates,et al.  Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. , 1988, Molecular endocrinology.

[8]  A. Manni,et al.  Role of polyamines in the synthesis of prolactin-regulated growth factors by experimental breast cancer in culture , 1987, Breast Cancer Research and Treatment.

[9]  R. Derynck,et al.  Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production. , 1987, Molecular endocrinology.

[10]  E. Gelmann,et al.  Growth regulation of human breast carcinoma occurs through regulated growth factor secretion , 1987, Journal of cellular biochemistry.

[11]  N. Davidson,et al.  Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Herlyn,et al.  Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. , 1987, Cancer research.

[13]  L. Demers,et al.  Effects of progestins on growth of experimental breast cancer in culture: interaction with estradiol and prolactin and involvement of the polyamine pathway. , 1987, Cancer research.

[14]  M. Moore,et al.  Progestin effects on growth in the human breast cancer cell line T-47D--possible therapeutic implications. , 1987, Biochemical and biophysical research communications.

[15]  M. Herlyn,et al.  Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. , 1987, Archives of biochemistry and biophysics.

[16]  J. Hammond,et al.  Polyamines and autocrine control of tumor growth by prolactin in experimental breast cancer in culture. , 1986, Endocrinology.

[17]  H. Rochefort,et al.  Autocrine stimulation by estradiol-regulated growth factors of rat hormone-responsive mammary cancer: interaction with the polyamine pathway. , 1986, Cancer research.

[18]  S. Bates,et al.  Characterization of estrogen responsive transforming activity in human breast cancer cell lines. , 1986, Cancer research.

[19]  L. Murphy,et al.  Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. , 1986, Cancer research.

[20]  N. Coldham,et al.  Hormonal therapies for breast cancer: can progestogens stimulate growth? , 1986, Cancer letters.

[21]  M. Pontari,et al.  Autocrine stimulation by prolactin of hormone-responsive breast cancer growth in culture. , 1985, Endocrinology.

[22]  R. Sutherland,et al.  Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells. , 1985, Biochemical and biophysical research communications.

[23]  A. Manni,et al.  Polyamines as mediators of the effect of prolactin and growth hormone on the growth of N-nitroso-N-methylurea-induced rat mammary tumor cultured in vitro in soft agar. , 1985, Journal of the National Cancer Institute.

[24]  S. Shapiro,et al.  Two direct radioimmunoassays for 17 beta-estradiol evaluated for use in monitoring in vitro fertilization. , 1984, Clinical chemistry.

[25]  R. Brodows,et al.  Evaluation of a direct solid-phase radioimmunoassay for progesterone, useful for monitoring luteal function. , 1984, Clinical chemistry.

[26]  J. Mendelsohn,et al.  Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. , 1983, Molecular biology & medicine.

[27]  J. Mendelsohn,et al.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Manni,et al.  Effect of tamoxifen and alpha-difluoromethylornithine on clones of nitrosomethylurea-induced rat mammary tumor cells grown in soft agar culture. , 1983, Cancer research.

[29]  A. Manni,et al.  Hormone Dependency in iV-Nitrosomethylurea-Induced Rat Mammary Tumors* , 1982 .

[30]  Seymour Geisser,et al.  Statistical Principles in Experimental Design , 1963 .

[31]  L. Demers,et al.  Polyamines and the synthesis of estradiol-regulated growth factors in rat mammary cancer in culture , 2005, Breast Cancer Research and Treatment.

[32]  K. Horwitz,et al.  Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies. , 1985, Cancer research.

[33]  A. Manni,et al.  Hormone dependency in N-nitrosomethylurea-induced rat mammary tumors. , 1982, Endocrinology.